Your session is about to expire
← Back to Search
Blood flow restriction and standard of care therapy for Patellofemoral Pain Syndrome
Study Summary
This trial will study if a therapy can help improve outcomes for people with knee pain.
- Patellofemoral Pain Syndrome
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have received a knee injection in the past three months.You have a medical condition where your body is inflamed and it is not being controlled or treated.You have cancer in the same area where the treatment will be given, or below that area.Your diabetes is not well controlled and you have issues with numbness or poor blood flow in your limbs.You have had rhabdomyolysis in the past or currently have it.You have had surgery to remove lymph nodes.You have varicose veins or a history of blood clots in your deep veins or if your parents or siblings have had blood clots.You have wounds or pain below your knee that is severe, rated as a 4 out of 10 or higher.
- Group 1: Sham and standard of care therapy
- Group 2: Blood flow restriction and standard of care therapy
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many health centers are currently conducting this trial?
"This clinical trial is being conducted at 5 sites: Gaylord Specialty Healthcare Outpatient Physical Therapy; Cheshire, Gaylord Specialty Healthcare Outpatient Physical Therapy; Cromwell, University of Connecticut Health Center in Farmington and 2 additional medical facilities."
Are there still opportunities to become involved in this research endeavor?
"As recently recorded on clinicaltrials.gov, this research initiative is still actively seeking participants for their trial. It was initially posted in November 15th 2022 and the latest update to the study occurred that same day."
What is the uppermost limit of individuals participating in this trial?
"Affirmative, the clinical trial is still open for enrollment. It was initially posted on November 15th 2022 and has since been updated to its current version. 96 individuals are being sought from five distinct sites."
What are the primary objectives of this research endeavor?
"This trial's primary outcome is to measure the Numeric Pain Rating Scale at 12 months post-enrollment. Secondary measurements will include Quadricep Isometric Strength tested 9 weeks after enrollment, 1 week into treatment and 4 weeks following it using an isometry dynamometer."
Share this study with friends
Copy Link
Messenger